These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20417530)

  • 1. [Calcified aortic valve disease: association with atherosclerosis].
    Toro R; Mangas A; Gómez F
    Med Clin (Barc); 2011 May; 136(13):588-93. PubMed ID: 20417530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcific aortic valve disease: is it another face of atherosclerosis?
    Sathyamurthy I; Alex S
    Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of statins in vascular and valvular calcification].
    Kozaki K
    Clin Calcium; 2006 Jan; 16(1):31-6. PubMed ID: 16397348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis.
    Yamamoto K; Yamamoto H; Yoshida K; Kisanuki A; Hirano Y; Ohte N; Akasaka T; Takeuchi M; Nakatani S; Ohtani T; Sozu T; Masuyama T
    Hypertens Res; 2010 Mar; 33(3):269-74. PubMed ID: 20057483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid theory in the pathogenesis of calcific aortic stenosis.
    Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments.
    Myasoedova VA; Ravani AL; Frigerio B; Valerio V; Moschetta D; Songia P; Poggio P
    Pharmacol Res; 2018 Oct; 136():74-82. PubMed ID: 30149054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcified aortic valve disease complicated with and without diabetes mellitus: the underlying pathogenesis.
    Chen Y; Xiao F; Wang R
    Rev Cardiovasc Med; 2022 Jan; 23(1):7. PubMed ID: 35092199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?
    Mazzone A; Epistolato MC; Gianetti J; Castagnini M; Sassi C; Ceravolo R; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
    Am J Clin Pathol; 2006 Oct; 126(4):494-502. PubMed ID: 16938654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with statins and angiotensin-converting enzyme inhibitors in degenerative aortic stenosis--an up-date].
    Moldovanu CM; Pandele GI; Ambăruş V; Ionescu S
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):964-74. PubMed ID: 20191861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and genetics of calcific aortic valve disease.
    O'Brien KD
    J Investig Med; 2007 Sep; 55(6):284-91. PubMed ID: 17963677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis.
    Allison MA; Cheung P; Criqui MH; Langer RD; Wright CM
    Circulation; 2006 Feb; 113(6):861-6. PubMed ID: 16461818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular mechanisms of aortic stenosis.
    Yetkin E; Waltenberger J
    Int J Cardiol; 2009 Jun; 135(1):4-13. PubMed ID: 19386374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it time to prescribe statins to patients with calcified aortic stenosis?
    Rashidi A; Adler DS; Casscells W; Madjid M
    Am Heart J; 2005 Jul; 150(1):41-5. PubMed ID: 16084149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of statins to retard the progression of aortic stenosis.
    Rajamannan NM
    Curr Cardiol Rep; 2007 Apr; 9(2):99-104. PubMed ID: 17430676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of statins in aortic stenosis. Myth or reality?
    Moura LM; Zamorano J; Peréz-Oteyza C; Rocha-Gonçlves F; Rajamannan NM
    Rev Port Cardiol; 2007 Jan; 26(1):51-62. PubMed ID: 17427836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy for calcific aortic stenosis.
    Salas MJ; Santana O; Escolar E; Lamas GA
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):133-8. PubMed ID: 21828284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.